Green Cross Drug, Microsoft, Twitter: Intellectual Property
This article is for subscribers only.
Green Cross Holdings Corp., a Korean company with pharmaceutical holdings, lost its appeal of denial of a patent in India for a hemophilia drug, the Hindu newspaper reported.
The Indian Intellectual Property Appellate Board said that the drug failed to “constitute a patentable contribution,” according to the newspaper.